# 🏦 Big bank earnings officially kicked off earnings season Major banks including: * JPMorgan Chase * Goldman Sachs * Bank of America * Citigroup reported quarterly results. **Highlights** * Goldman Sachs impressed investors with stronger-than-expected earnings. * Several banks …
# 📉 Top Losers (Under $5) |Ticker|Price|% Loss|Likely Catalyst| |:-|:-|:-|:-| |**USDE**|$3.70|**-60.64%**|Heavy selling pressure after a sharp prior run-up. | |**CELZ**|$1.20|**-40.00%**|Profit-taking and biotech sector weakness. | |**LICN**|$1.02|**-38.92%**|Small-cap Chinese stock volatility. | |**TVRD**|$1.50|**-36.44%**|Selling after recent speculative gains. | |**UBXG**|$4.28|**-32.06%**|High-volume selloff with no …
# 🚀 Top Gainers |Ticker|Price|% Gain|Likely Catalyst| |:-|:-|:-|:-| |**GMM**|$4.57|**+147.03%**|Heavy speculative buying, unusually high trading volume. | |**JZXN**|$2.17|**+85.47%**|Momentum trade with very high volume. | |**ZBAO**|$0.42|**+43.18%**|Strong retail interest and speculative buying. | |**YMAT**|$2.44|**+28.42%**|Increased buying activity following recent market interest. | |**LGHL**|$2.94|**+34.71%**|Unusually high …
Just saw the new VisionWave Holdings (Nasdaq: VWAV) announcement today about SkyWeave, and this could be one of the company’s most interesting technology developments yet. VisionWave has filed a U.S. provisional patent application covering an AI-orchestrated communication ecosystem designed to …
$VSEE - "Electronic medical records digitized healthcare information. Telehealth expanded access to care. We believe AI-enabled enterprise infrastructure has the potential to help health systems operate more efficiently, while improving the experience for both patients and providers." https://finance.yahoo.com/healthcare/articles/vsee-health-vision-ai-enabled-130000266.html
Since 2025, ZBAO’s core insurance brokerage revenue reached 277 million yuan, representing a 51% year-on-year increase with a gross profit margin of 40.7%. The firm expanded its channel footprint via acquired brokerage licenses yet swung from profit to a net …
Spero spending GSK milestone money to purchase asset from Innovent Biologics? A deal with Innovent Biologics to license rights to a new asset to enter a Phaze 2 FDA trial in US? Fierce Pharma had an article this morning detailing …
Hi, I would like to briefly introduce Egetis Therapeutics, a Swedish biotech company and a candidate for the next catalyst play, and I am curious to hear your opinions on it. I’m honestly surprised that almost nobody has this stock …
I was going through recent GPUS insider transactions and noticed something that may be worth a closer look. Over roughly the last three months, GPUS CEO William Horne, Executive Chairman Milton Ault, and an Ault-controlled entity appear to have purchased …
Here is my once in a lifetime Pepe Silvia post: Esophageal cancer (EC) is one of the most deadly cancers, and incidence has increased something like 400-600% since 1975 (depending on the study). It can be cured entirely when it's …